Research Article

Efficacy of the GnRH Agonist Trigger in Oocyte and Embryo Quality Through Mitochondrial Unfolded Protein Response

Volume: 14 Number: 1 April 24, 2024
EN

Efficacy of the GnRH Agonist Trigger in Oocyte and Embryo Quality Through Mitochondrial Unfolded Protein Response

Abstract

Objective: Gonadotropin-releasing hormone agonist (GnRHa) trigger induces both Luteinizing hormone (LH) and follicle stimulating hormone (FSH) surges, impacting oocyte maturation, and mitochondrial dysfunction, is responsible for chromosomal anomalies during meiotic divisions. This study aimed to investigate the effect of GnRHa instead of human chorionic gonadotropin (hCG) triggers on unfolded protein responses against embryonic stress in oocytes and embryos. Materials and Methods: Female mice were divided into control, hCG-triggered, and GnRHa-triggered groups. Superovulation was performed. Oocytes were retrieved 13h after hCG or GnRHa injection, and two pronuclei (2PN) oocytes were retrieved 24h after the appearance of a vaginal plug. ATF5, GRP78, and HSP60 protein levels were analyzed by Western blot. One-way ANOVA and Students' t-test were used for statistical analysis. Results: When comparing the GnRHa group to the hCG group, their respective oocyte maturation rates (79.8% vs. 75.9%), oocyte areas (10198 μm2 and 9474 μm2), 2PN rates (78% vs. 72%), and blastocyst formation rates (82% vs. 77%) were significantly higher (p < 0.05). The HSP60 protein level was significantly lower in the GnRHa group compared to the hCG group (22% vs. 55%, p < 0.05). Additionally, the ATF5 protein level was significantly lower in the hCG group compared to the GnRHa group (p < 0.0001). Conclusion: GnRHa trigger improves oocyte nuclear and cytoplasmic maturation, as well as blastocyst formation rates. The underlying mechanism for this effect is the downregulation of HSP60 and upregulation of ATF5 levels.

Keywords

References

  1. Hu KL, Wang S, Ye X, Zhang D, Hunt S. GnRH agonist and hCG (dual trigger) versus hCG trigger for follicular maturation: a systematic review and meta-analysis of randomized trials. Reprod Biol Endocrinol 2021; 19(1): 78. google scholar
  2. Gao F, Wang Y, Fu M, Zhang Q, Ren Y, Shen H, Han H. Effect of a “Dual Trigger” using a GnRH agonist and hCG on the cumulative live-birth rate for normal responders in GnRH-antagonist cycles. Front Med (Lausanne) 2021; 8: 683210. google scholar
  3. Griesinger G, Diedrich K, Devroey P, Kolibianakis EM. GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis. Hum Reprod Update 2006; 12(2): 159-68. google scholar
  4. Basar M, Bozkurt I, Guzeloglu-Kayisli O, Sozen B, Tekmen I, Schatz F, et al. Unfolded protein response prevents blastocyst formation during preimplantation embryo development in vitro. Fertil Steril 2014; 102(6): 1777-84. google scholar
  5. Khatun H, Ihara Y, Takakura K, Egashira J, Wada Y, Konno T, et al. Role of endoplasmic reticulum stress on developmental competency and cryo-tolerance in bovine embryos. Theriogenology 2020; 142: 131-7. google scholar
  6. Michalak M, Gye MC. Endoplasmic reticulum stress in periimplantation embryos. Clin Exp Reprod Med 2015; 42(1) :1-7. google scholar
  7. Kumar R, Chaudhary AK, Woytash J, Inigo JR, Gokhale AA, Bshara W, et al. A mitochondrial unfolded protein response inhibitor suppresses prostate cancer growth in mice via HSP60. J Clin Invest 2022; 132(13): e149906. google scholar
  8. Seli E, Lalioti MD, Flaherty SM, Sakkas D, Terzi N, Steitz JA. An embryonic poly(A)-binding protein (ePAB) is expressed in mouse oocytes and early preimplantation embryos. Proc Natl Acad Sci U S A 2005; 102(2): 367-72. google scholar

Details

Primary Language

English

Subjects

Biochemistry and Cell Biology (Other)

Journal Section

Research Article

Publication Date

April 24, 2024

Submission Date

December 7, 2023

Acceptance Date

February 20, 2024

Published in Issue

Year 2024 Volume: 14 Number: 1

APA
Basar, M. (2024). Efficacy of the GnRH Agonist Trigger in Oocyte and Embryo Quality Through Mitochondrial Unfolded Protein Response. Experimed, 14(1), 21-25. https://doi.org/10.26650/experimed.1401479
AMA
1.Basar M. Efficacy of the GnRH Agonist Trigger in Oocyte and Embryo Quality Through Mitochondrial Unfolded Protein Response. Experimed. 2024;14(1):21-25. doi:10.26650/experimed.1401479
Chicago
Basar, Murat. 2024. “Efficacy of the GnRH Agonist Trigger in Oocyte and Embryo Quality Through Mitochondrial Unfolded Protein Response”. Experimed 14 (1): 21-25. https://doi.org/10.26650/experimed.1401479.
EndNote
Basar M (April 1, 2024) Efficacy of the GnRH Agonist Trigger in Oocyte and Embryo Quality Through Mitochondrial Unfolded Protein Response. Experimed 14 1 21–25.
IEEE
[1]M. Basar, “Efficacy of the GnRH Agonist Trigger in Oocyte and Embryo Quality Through Mitochondrial Unfolded Protein Response”, Experimed, vol. 14, no. 1, pp. 21–25, Apr. 2024, doi: 10.26650/experimed.1401479.
ISNAD
Basar, Murat. “Efficacy of the GnRH Agonist Trigger in Oocyte and Embryo Quality Through Mitochondrial Unfolded Protein Response”. Experimed 14/1 (April 1, 2024): 21-25. https://doi.org/10.26650/experimed.1401479.
JAMA
1.Basar M. Efficacy of the GnRH Agonist Trigger in Oocyte and Embryo Quality Through Mitochondrial Unfolded Protein Response. Experimed. 2024;14:21–25.
MLA
Basar, Murat. “Efficacy of the GnRH Agonist Trigger in Oocyte and Embryo Quality Through Mitochondrial Unfolded Protein Response”. Experimed, vol. 14, no. 1, Apr. 2024, pp. 21-25, doi:10.26650/experimed.1401479.
Vancouver
1.Murat Basar. Efficacy of the GnRH Agonist Trigger in Oocyte and Embryo Quality Through Mitochondrial Unfolded Protein Response. Experimed. 2024 Apr. 1;14(1):21-5. doi:10.26650/experimed.1401479